SAK Corp., 10% Owner at IDENIX PHARMACEUTICALS INC (IDIX), bought 16,420,241 shares at $6.50 ($106.7M) on 2014-01-31, disclosed to the SEC on 2014-02-04.
Open-market purchase of $106.7M IDIX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| RHIE | BUY | 2009-01-16 | $1.8M | — | Filing → |